Cargando…
Nasal High-Flow Therapy: Role of Fi(O(2)) in the ROX Index
Autor principal: | Tatkov, Stanislav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603067/ https://www.ncbi.nlm.nih.gov/pubmed/30896967 http://dx.doi.org/10.1164/rccm.201902-0376LE |
Ejemplares similares
-
Success or Failure of High-Flow Nasal Oxygen Therapy: The ROX Index Is Good, but a Modified ROX Index May Be Better
por: Karim, Habib M. R., et al.
Publicado: (2019) -
ROX index and SpO(2)/FiO(2) ratio for predicting high-flow nasal cannula failure in hypoxemic COVID-19 patients: A multicenter retrospective study
por: Kim, Jin Hyoung, et al.
Publicado: (2022) -
Mechanisms of nasal high flow therapy in newborns
por: Mazmanyan, Pavel, et al.
Publicado: (2020) -
The Relationship of Respiratory Rate-Oxygenation (ROX) and Modified ROX Index With High-Flow Nasal Cannula Oxygen Therapy in COVID-19 Patients: An Observational Pilot Study
por: Karim, Habib Md R, et al.
Publicado: (2022) -
Effect of flow and cannula size on generated pressure during nasal high flow
por: Pinkham, Maximilian, et al.
Publicado: (2020)